Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, representing a small maintenance update without visible content changes.
    Difference
    0.1%
    Check dated 2026-06-05T08:42:09.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision label v3.5.4 was added, replacing the previous v3.5.3 to denote a minor build/version update for the page. This reflects maintenance or a status update rather than changes to study information or outcomes.
    Difference
    0.1%
    Check dated 2026-05-15T03:23:14.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, signaling an updated version of the page documentation. Aside from this metadata update, the page content and structure appear unchanged.
    Difference
    0.1%
    Check dated 2026-04-30T18:38:29.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Footer shows site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:38:56.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Administrative revision update: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:12.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:26.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.